This series is a part of the BRET office's ASPIRE program and presented by the CTTC and focused to help educate students about alternative career paths while also providing educational content about those fields of work.
This session will cover an overview of the regulatory pathway for various products. Maneuvering the FDA can cause lengthy delays in product launch if the incorrect pathway is chosen, or if guidelines are not followed. A good regulatory strategy is essential in all biotech companies.
As part of a federal grant, it is requested that at each event you sign in that you attended for grant reporting requirements.
Presenter: Axel Strombergsson, M.Sc, Regulatory Affairs Officer, CTTC
Who is it for: Vanderbilt faculty, staff and students
When: November 9, 2015 3:00-4:00pm
Where: Light Hall 407 A-D
https://medschool.vanderbilt.edu/career-development/blog/2015-aspire-mod...